Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell L Margolis

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
Molecular Neuropsychiatry|November 22, 2016
A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein AggregationLeslie G Nucifora, YeeWen Candace Wu, Brian J Lee, et al.
Movement Disorders Clinical Practice|October 11, 2025
Huntington's Disease and Huntington's Disease-like 2 (HDL2) in MartiniqueIgnacio Antolin-Sanfeliz, Anna-Gaelle Giguet-Valard, Sophie Duclos, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|December 12, 2017
Absence of Acanthocytosis in Huntington's Disease-like 2: A Prospective Comparison with Huntington's DiseaseDavid G Anderson, Sergio Carmona, Kubendran Naidoo, et al.
The Journal of Biological Chemistry|June 10, 2011
Inositol hexakisphosphate kinases induce cell death in Huntington diseaseEiichiro Nagata, Adolfo Saiardi, Hideo Tsukamoto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 10, 2005
Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cellsWanli W Smith, Russell L Margolis, Xiaojie Li, et al.
American Journal of Medical Genetics. Part A|May 13, 2005
FXTAS, SCA10, and SCA17 in American patients with movement disordersAna I Seixas, Martin H Maurer, Mark Lin, et al.
The Journal of Nervous and Mental Disease|February 2, 2016
Perspectives on the Use of eHealth in the Management of Patients With SchizophreniaGlenn J Treisman, Geetha Jayaram, Russell L Margolis, et al.
Schizophrenia Research|November 25, 2020
Better functional capacity and cognitive performance in clozapine responders compared to non-responders: A cross-sectional studyFrederick C Nucifora, Krista K Baker, Ashley Stricklin, et al.
Annals of Neurology|February 28, 2012
Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesisAna I Seixas, Susan E Holmes, Hiroshi Takeshima, et al.
Neurobiology of Disease|March 20, 2012
Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegenerationRainer Prohaska, Ody C M Sibon, Dobrila D Rudnicki, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Molecular Neuropsychiatry|November 22, 2016
A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein AggregationLeslie G Nucifora, YeeWen Candace Wu, Brian J Lee, et al.
Movement Disorders Clinical Practice|October 11, 2025
Huntington's Disease and Huntington's Disease-like 2 (HDL2) in MartiniqueIgnacio Antolin-Sanfeliz, Anna-Gaelle Giguet-Valard, Sophie Duclos, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|December 12, 2017
Absence of Acanthocytosis in Huntington's Disease-like 2: A Prospective Comparison with Huntington's DiseaseDavid G Anderson, Sergio Carmona, Kubendran Naidoo, et al.
The Journal of Biological Chemistry|June 10, 2011
Inositol hexakisphosphate kinases induce cell death in Huntington diseaseEiichiro Nagata, Adolfo Saiardi, Hideo Tsukamoto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 10, 2005
Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cellsWanli W Smith, Russell L Margolis, Xiaojie Li, et al.
American Journal of Medical Genetics. Part A|May 13, 2005
FXTAS, SCA10, and SCA17 in American patients with movement disordersAna I Seixas, Martin H Maurer, Mark Lin, et al.
The Journal of Nervous and Mental Disease|February 2, 2016
Perspectives on the Use of eHealth in the Management of Patients With SchizophreniaGlenn J Treisman, Geetha Jayaram, Russell L Margolis, et al.
Schizophrenia Research|November 25, 2020
Better functional capacity and cognitive performance in clozapine responders compared to non-responders: A cross-sectional studyFrederick C Nucifora, Krista K Baker, Ashley Stricklin, et al.
Annals of Neurology|February 28, 2012
Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesisAna I Seixas, Susan E Holmes, Hiroshi Takeshima, et al.
Neurobiology of Disease|March 20, 2012
Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegenerationRainer Prohaska, Ody C M Sibon, Dobrila D Rudnicki, et al.
Pageof 13